Dr. Dalman's laboratory are investigating the biologic and mechanical basis of aneurysmal degeneration of the aorta. They use molecular, imaging and computer modeling modalities to identify novel treatment strategies for small AAAs and hybrid drug/device surgical solutions for larger AAAs.

By extension they are keenly interested in new surgical technology and its application to aneurysmal and occlusive arterial and venous diseases. To this end they have completed over 50 drug and device clinical trials from dozens of governmental and commercial sponsors in our SUMC and VA clinical practices. They are currently enrolling patients in over a dozen clinical trials at both sites. Please review our website (vascular.stanford.edu) for updates regarding clinical trials and eligibility criteria.